The purpose of this study is to assess the efficacy and safety of Newrabell® Tab. in patients with refractory reflux esophagitis to the prior standard PPIs regimen.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
39
Chonnam National University Hospital
Gwangju, Donggu, Jebongro, South Korea
Chonnam National University Hwasun Hospital
Gwangju, Hwasun-eup,Hwasun-gun, South Korea
Time to onset of first 1Day Heartburn free, Days
Time frame: up to 8 weeks
Time to onset of first 2Days Heartburn free, Days
Time frame: up to 8 weeks
1Day Heartburn free days, %
Time frame: up to 8 weeks
Time in Daytime of first Heartburn free, Days
Time frame: up to 8 weeks
Time in Nighttime of first Heartburn free, Days
Time frame: up to 8 weeks
Weekly Heartburn Improvement Rate, %
Time frame: up to 8 weeks
Average Daytime and Nighttime Heartburn Score Change at W4
Time frame: up to 8 weeks
Average Daytime and Nighttime Heartburn Score Change at W8
Time frame: up to 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.